Free Trial

ZyVersa Therapeutics (ZVSA) Competitors

ZyVersa Therapeutics logo
$0.54 -0.01 (-1.33%)
Closing price 03:57 PM Eastern
Extended Trading
$0.55 +0.01 (+1.16%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZVSA vs. ENSC, AEON, SNOA, APM, KLTO, DRMA, TTNP, EVOK, TCRT, and CDT

Should you be buying ZyVersa Therapeutics stock or one of its competitors? The main competitors of ZyVersa Therapeutics include Ensysce Biosciences (ENSC), AEON Biopharma (AEON), Sonoma Pharmaceuticals (SNOA), Aptorum Group (APM), Klotho Neurosciences (KLTO), Dermata Therapeutics (DRMA), Titan Pharmaceuticals (TTNP), Evoke Pharma (EVOK), Alaunos Therapeutics (TCRT), and Conduit Pharmaceuticals (CDT). These companies are all part of the "pharmaceutical products" industry.

ZyVersa Therapeutics vs.

ZyVersa Therapeutics (NASDAQ:ZVSA) and Ensysce Biosciences (NASDAQ:ENSC) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking and valuation.

In the previous week, Ensysce Biosciences had 1 more articles in the media than ZyVersa Therapeutics. MarketBeat recorded 4 mentions for Ensysce Biosciences and 3 mentions for ZyVersa Therapeutics. Ensysce Biosciences' average media sentiment score of 1.04 beat ZyVersa Therapeutics' score of 0.66 indicating that Ensysce Biosciences is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ZyVersa Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Ensysce Biosciences
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

3.9% of ZyVersa Therapeutics shares are owned by institutional investors. Comparatively, 5.6% of Ensysce Biosciences shares are owned by institutional investors. 0.2% of ZyVersa Therapeutics shares are owned by insiders. Comparatively, 7.9% of Ensysce Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

ZyVersa Therapeutics and Ensysce Biosciences both received 3 outperform votes by MarketBeat users. However, 100.00% of users gave ZyVersa Therapeutics an outperform vote while only 60.00% of users gave Ensysce Biosciences an outperform vote.

CompanyUnderperformOutperform
ZyVersa TherapeuticsOutperform Votes
3
100.00%
Underperform Votes
No Votes
Ensysce BiosciencesOutperform Votes
3
60.00%
Underperform Votes
2
40.00%

ZyVersa Therapeutics has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Ensysce Biosciences has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500.

Ensysce Biosciences has higher revenue and earnings than ZyVersa Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZyVersa TherapeuticsN/AN/A-$98.30MN/AN/A
Ensysce Biosciences$2.23M2.31-$10.61M-$6.54-0.33

ZyVersa Therapeutics has a net margin of 0.00% compared to Ensysce Biosciences' net margin of -179.26%. ZyVersa Therapeutics' return on equity of -224.85% beat Ensysce Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ZyVersa TherapeuticsN/A -224.85% -103.22%
Ensysce Biosciences -179.26%-292.81%-158.83%

Summary

Ensysce Biosciences beats ZyVersa Therapeutics on 7 of the 11 factors compared between the two stocks.

Get ZyVersa Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZVSA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZVSA vs. The Competition

MetricZyVersa TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.59M$6.48B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E RatioN/A9.0626.7119.71
Price / SalesN/A251.50386.13120.55
Price / CashN/A65.8538.2534.62
Price / Book0.016.456.774.50
Net Income-$98.30M$143.98M$3.23B$248.22M
7 Day Performance5.79%2.41%1.80%0.56%
1 Month Performance-18.39%4.56%11.10%13.17%
1 Year Performance-87.69%-2.67%17.11%7.30%

ZyVersa Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZVSA
ZyVersa Therapeutics
0.6266 of 5 stars
$0.54
-1.3%
N/A-87.5%$2.59MN/A0.002News Coverage
ENSC
Ensysce Biosciences
0.2418 of 5 stars
$2.19
+0.9%
N/A-78.1%$5.19M$2.23M-0.0810Gap Up
AEON
AEON Biopharma
2.9463 of 5 stars
$0.49
+3.9%
$360.00
+73,070.7%
-99.6%$5.18MN/A2.735News Coverage
SNOA
Sonoma Pharmaceuticals
0.2365 of 5 stars
$3.17
+0.6%
N/A+1,533.2%$5.09M$13.97M-0.79180Positive News
Gap Up
APM
Aptorum Group
0.354 of 5 stars
$0.93
+7.9%
N/A-76.6%$4.97M$430,000.000.0030Positive News
KLTO
Klotho Neurosciences
N/A$0.17
+5.0%
N/AN/A$4.89MN/A0.00N/APositive News
Earnings Report
High Trading Volume
DRMA
Dermata Therapeutics
1.3163 of 5 stars
$0.79
-2.0%
$6.00
+655.7%
-77.5%$4.79MN/A-0.058Positive News
Analyst Forecast
TTNP
Titan Pharmaceuticals
0.19 of 5 stars
$5.23
+2.8%
N/A-31.7%$4.78M$180,000.00-1.0010Analyst Forecast
Gap Up
EVOK
Evoke Pharma
0.1066 of 5 stars
$3.11
-1.1%
N/A-36.3%$4.69M$10.25M-0.284Negative News
Gap Up
TCRT
Alaunos Therapeutics
1.1132 of 5 stars
$2.85
flat
N/A-76.3%$4.67M$10,000.000.0040Positive News
Earnings Report
Gap Down
CDT
Conduit Pharmaceuticals
0.7041 of 5 stars
$0.41
+2.3%
N/A-99.9%$4.64MN/A-0.013News Coverage
Earnings Report
Stock Split

Related Companies and Tools


This page (NASDAQ:ZVSA) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners